SEARCH

SEARCH BY CITATION

References

  • Asnafi, V., Buzyn, A., Le Noir, S., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., Turlure, P., Leguay, T., Huguet, F., Vernant, J.P., Daniel, F., Béné, M.C., Ifrah, N., Thomas, X., Dombret, H. & Macintyre, E. (2009) NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood, 113, 39183924.
  • Baldus, C.D., Thibaut, J., Goekbuget, N., Stroux, A., Schlee, C., Mossner, M., Burmeister, T., Schwartz, S., Bloomfield, C.D., Hoelzer, D., Thiel, E. & Hofmann, W.K. (2009) Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica, 94, 13831390.
  • Ben Abdelali, R., Asnafi, V., Leguay, T., Boissel, N., Buzyn, A., Chevallier, P., Thomas, X., Lepretre, S., Huguet, F., Vey, N., Escoffre-Barbe, M., Tavernier, E., Reman, O., Fegueux, N., Turlure, P., Rousselot, P., Cahn, J.Y., Lheritier, V., Chalandon, Y., Béné, M.C., Macintyre, E., Dombret, H., Ifrah, N. & Group for Research on Adult Acute Lymphoblastic Leukemia. (2011) Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study. Blood, 118, 50995107.
  • Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.D., Tolle, G., Happich, M., Muckenthaler, M.U. & Kulozik, A.E. (2006) Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood, 108, 11511157.
  • Clappier, E., Collette, S., Grardel, N., Girard, S., Suarez, L., Brunie, G., Kaltenbach, S., Yakouben, K., Mazingue, F., Robert, A., Boutard, P., Plantaz, D., Rohrlich, P., van Vlierberghe, P., Preudhomme, C., Otten, J., Speleman, F., Dastugue, N., Suciu, S., Benoit, Y., Bertrand, Y., Cavé, H. & EORTC-CLG. (2010) NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia, 24, 20232031.
  • Cui, L., Li, Z., Wu, M., Li, W., Gao, C. & Deng, G. (2010) Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia. Leukemia Research, 34, 13141319.
  • Demarest, R.M., Ratti, F. & Capobianco, A.J. (2008) It's T-ALL about Notch. Oncogene, 27, 50825091.
  • Demarest, R.M., Dahmane, N. & Capobianco, A.J. (2011) Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia. Blood, 117, 29012909.
  • Erbilgin, Y., Sayitoglu, M., Hatirnaz, O., Dogru, O., Akcay, A., Tuysuz, G., Celkan, T., Aydogan, G., Salcioglu, Z., Timur, C., Yuksel-Soycan, L., Ure, U., Anak, S., Agaoglu, L., Devecioglu, O., Yildiz, I. & Ozbek, U. (2010) Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Disease Markers, 28, 353360.
  • Flohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grümayer, R., van der Velden, V., Fischer, S., Stanulla, M., Basso, G., Niggli, F.K., Schäfer, B.W., Sutton, R., Koehler, R., Zimmermann, M., Valsecchi, M.G., Gadner, H., Masera, G., Schrappe, M., van Dongen, J.J., Biondi, A., Bartram, C.R. & International BFM Study Group (I-BFM-SG). (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22, 771782.
  • Gao, C., Zhao, X.X., Li, W.J., Cui, L., Zhao, W., Liu, S.G., Yue, Z.X., Jiao, Y., Wu, M.Y. & Li, Z.G. (2012) Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients. American Journal of Hematology, 87, 10221027.
  • van Grotel, M., Meijerink, J.P., van Wering, E.R., Langerak, A.W., Beverloo, H.B., Buijs-Gladdines, J.G., Burger, N.B., Passier, M., van Lieshout, E.M., Kamps, W.A., Veerman, A.J., van Noesel, M.M. & Pieters, R. (2008) Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia, 22, 124131.
  • Hilden, J.M., Dinndorf, P.A., Meerbaum, S.O., Sather, H., Villaluna, D., Heerema, N.A., McGlennen, R., Smith, F.O., Woods, W.G., Salzer, W.L., Johnstone, H.S., Dreyer, Z., Reaman, G.H. & Children's Oncology Group. (2006) Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood, 108, 441451.
  • Jen, K.Y., Song, I.Y., Banta, K.L., Wu, D., Mao, J.H. & Balmain, A. (2012) Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Blood, 119, 805809.
  • Jenkinson, S., Koo, K., Mansour, M.R., Goulden, N., Vora, A., Mitchell, C., Wade, R., Richards, S., Hancock, J., Moorman, A.V., Linch, D.C. & Gale, R.E. (2013) Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. Leukemia, 27, 4147.
  • Kox, C., Zimmermann, M., Stanulla, M., Leible, S., Schrappe, M., Ludwig, W.D., Koehler, R., Tolle, G., Bandapalli, O.R., Breit, S., Muckenthaler, M.U. & Kulozik, A.E. (2010) The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia, 24, 20052013.
  • Larson Gedman, A., Chen, Q., Kugel Desmoulin, S., Ge, Y., La Fiura, K., Haska, C.L., Cherian, C., Devidas, M., Linda, S.B., Taub, J.W. & Matherly, L.H. (2009) The impact of NOTCH1, FBW7, and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia, 23, 14171425.
  • Malyukova, A., Dohda, T., von der Lehr, N., Akhoondi, S., Corcoran, M., Heyman, M., Spruck, C., Grandér, D., Lendahl, U. & Sangfelt, O. (2007) The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Research, 67, 56115616.
  • Mansour, M.R., Linch, D.C., Foroni, L., Goldstone, A.H. & Gale, R.E. (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia, 20, 537539.
  • Mansour, M.R., Sulis, M.L., Duke, V., Foroni, L., Jenkinson, S., Koo, K., Allen, C.G., Gale, R.E., Buck, G., Richards, S., Paietta, E., Rowe, J.M., Tallman, M.S., Goldstone, A.H., Ferrando, A.A. & Linch, D.C. (2009) Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. Journal of Clinical Oncology, 27, 43524356.
  • Mansur, M.B., Hassan, R., Barbosa, T.C., Splendore, A., Jotta, P.Y., Yunes, J.A., Wiemels, J.L. & Pombo-de-Oliveira, M.S. (2012) Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukemia. BMC Cancer, 12, 9.
  • Park, M.J., Taki, T., Oda, M., Watanabe, T., Yumura-Yagi, K., Kobayashi, R., Suzuki, N., Hara, J., Horibe, K. & Hayashi, Y. (2009) FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. British Journal of Haematology, 145, 198206.
  • Pui, C.H., Carroll, W.L., Meshinchi, S. & Arceci, R.J. (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: an update. Journal of Clinical Oncology, 29, 551565.
  • Sanchez-Irizarry, C., Carpenter, A.C., Weng, A.P., Pear, W.S., Aster, J.C. & Blacklow, S.C. (2004) Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Molecular and Cellular Biology, 24, 92659273.
  • Schrappe, M., Valsecchi, M.G., Bartram, C.R., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B., Reiter, A., Basso, G., Klingebiel, T., Messina, C., Ratei, R., Cazzaniga, G., Koehler, R., Locatelli, F., Schäfer, B.W., Aricò, M., Welte, K., van Dongen, J.J., Gadner, H., Biondi, A. & Conter, V. (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118, 20772084.
  • Thompson, B.J., Buonamici, S., Sulis, M.L., Palomero, T., Vilimas, T., Basso, G., Ferrando, A. & Aifantis, I. (2007) The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. The Journal of Experimental Medicine, 204, 18251835.
  • Trinquand, A., Tanguy-Schmidt, A., Ben Abdelali, R., Lambert, J., Beldjord, K., Lengliné, E., De Gunzburg, N., Payet-Bornet, D., Lhermitte, L., Mossafa, H., Lhéritier, V., Bond, J., Huguet, F., Buzyn, A., Leguay, T., Cahn, J.Y., Thomas, X., Chalandon, Y., Delannoy, A., Bonmati, C., Maury, S., Nadel, B., Macintyre, E., Ifrah, N., Dombret, H. & Asnafi, V. (2013) Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia Study. Journal of Clinical Oncology, 31, 43334342.
  • Weerkamp, F., van Dongen, J.J. & Staal, F.J. (2006) Notch and Wnt signalling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia, 20, 11971205.
  • Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P. 4th, Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. & Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269271.
  • Zhu, Y.M., Zhao, W.L., Fu, J.F., Shi, J.Y., Pan, Q., Hu, J., Gao, X.D., Chen, B., Li, J.M., Xiong, S.M., Gu, L.J., Tang, J.Y., Liang, H., Jiang, H., Xue, Y.Q., Shen, Z.X., Chen, Z. & Chen, S.J. (2006) NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clinical Cancer Research, 12, 30433049.
  • Zuurbier, L., Homminga, I., Calvert, V., te Winkel, M.L., Buijs-Gladdines, J.G., Kooi, C., Smits, W.K., Sonneveld, E., Veerman, A.J., Kamps, W.A., Horstmann, M., Petricoin, E.F. 3rd, Pieters, R. & Meijerink, J.P. (2010) NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia, 24, 20142022.